Fluorescence in Situ Hybridization Study of HER-2/neu Oncogene Amplification in Prostate Cancer
- 30 June 1999
- journal article
- Published by Elsevier in Experimental and Molecular Pathology
- Vol. 66 (2) , 170-178
- https://doi.org/10.1006/exmp.1999.2242
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- HER-2/neu gene amplification in stages I-IV breast cancer detected by fluorescent in situ hybridizationGenetics in Medicine, 1999
- Fluorescentin situ hybridization assessment of chromosome 8 copy number in breast cancerBreast Cancer Research and Treatment, 1996
- c-erbB-2 Oncoprotein Overexpression in Uterine Cervix Carcinoma With Glandular Differentiation:A Frequent Event But Not an Independent Prognostic Marker Because It Occurs Late in the DiseaseAmerican Journal of Clinical Pathology, 1995
- The value of screening tests in the detection of prostate cancer. Part I: Results of a retrospective evaluation of 1726 menUrology, 1995
- Oncogene Protein Co-Expression Value of Ha-ras, c-myc, c-fos, and p53 as Prognostic Discriminants for Breast CarcinomaAnnals of Surgery, 1995
- Expression of c‐erb B‐2/neu proto‐oncogene in human prostatic cancer tissues and cell linesMolecular Carcinogenesis, 1992
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry.Journal of Histochemistry & Cytochemistry, 1983